Jubilant Ingrevia Ltd 14 May 2024 12:00 AM
Jubilant Ingrevia consolidated net profit declines 44.08% in the March 2024 quarter,
Net profit of Jubilant Ingrevia declined 44.08% to Rs 29.25 crore in the quarter ended March 2024 as against Rs 52.31 crore during the previous quarter ended March 2023. Sales declined 6.13% to Rs 1060.24 crore in the quarter ended March 2024 as against Rs 1129.48 crore during the previous quarter ended March 2023.For the full year,net profit declined 40.52% to Rs 182.89 crore in the year ended March 2024 as against Rs 307.50 crore during the previous year ended March 2023. Sales declined 13.50% to Rs 4100.45 crore in the year ended March 2024 as against Rs 4740.48 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales1060.241129.48 -6 4100.454740.48 -14 OPM %8.609.04 -10.2711.54 - PBDT87.07105.36 -17 403.78558.89 -28 PBT51.3575.52 -32 267.61436.71 -39 NP29.2552.31 -44 182.89307.50 -41 Powered by Capital Market - Live News
Jubilant Ingrevia Ltd 14 May 2024 12:00 AM
Board of Jubilant Ingrevia recommends Final Dividend,
Jubilant Ingrevia announced that the Board of Directors of the Company at its meeting held on 14 May 2024, has recommended a Final dividend of Rs.2.50 per share (i.e.250%), subject to the approval of the shareholders.Powered by Capital Market - Live News
Jubilant Ingrevia Ltd 04 May 2024 12:00 AM
Jubilant Ingrevia announces board meeting date,
Jubilant Ingrevia will hold a meeting of the Board of Directors of the Company on 14 May 2024.Powered by Capital Market - Live News
Jubilant Ingrevia Ltd 01 Apr 2024 12:00 AM
Jubilant Ingrevia commissions new facility for Diketene derivatives,
Jubilant Ingrevia announced the commissioning of a new facility at its manufacturing site for Diketene derivatives at Gajraula, Uttar Pradesh. As a global, integrated life science products and innovative solutions provider, the Company presently has over 134 products & innovative solutions commercialised. With over four decades of experience, it has developed proficiency across ~35 key chemistry and technology platforms across its businesses: Specialty, Nutrition and Chemical Intermediates. The newly commissioned facility adds additional capacity of ~2,000 TPA to produce high-value esters. This strengthening of the Diketene and derivatives platform marks a natural evolution of strategy in the Specialty Chemicals segment. This business is pivoting towards accelerated growth and higher margins with the introduction of several downstream derivatives.Powered by Capital Market - Live News
Jubilant Ingrevia Ltd 12 Mar 2024 12:00 AM
Jubilant Ingrevia partners with O2 Renewable,
Jubilant Ingrevia announced that it has partnered with O2 Renewable Energy XVIII (�O2 Renewable`, a group company of O2 Power SG, Singapore), a leading renewable energy developer. This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources. It aims to access renewable energy through a captive arrangement, fulfilling the Company`s power requirements and meeting its increasing demand from green energy to power its manufacturing facilities at Gajraula, Uttar Pradesh and Savli, Gujarat. This represents an important milestone in the Company`s sustainability journey by reducing dependence on non-renewable energy sources and reducing its carbon footprint.Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now